Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic Obstructive Pulmonary Disease Condition: Maintenance treatment of airflow obstruction |
Dose: Inhalation – 1 inhalation (25 mcg/62.5 mcg/100 mcg) Frequency: once daily Note: Administered by oral inhalation. No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with mild hepatic impairment. |
|
Indication: Asthma Age: greater than 18 years Condition: Maintenance treatment |
Dose: Inhalation – 1 inhalation (25 mcg/62.5 mcg/100 mcg) Frequency: once daily Note: Administered by oral inhalation. No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with mild hepatic impairment. |
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Details coming soon
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.